Methods and reagents for tumor targeting with greater efficacy and less toxicity
AssigneeCornell University
InventorNeil H. BANDER
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method for treating cancer. This method involves providing a first agent comprising a first targeting component coupled to a first cancer therapeutic component and providing a second agent comprising a second targeting component coupled to a second cancer therapeutic component. The first and second targeting components have different biodistributions and/or pharmacokinetics. The first and second agents are administered to a subject having cancer to treat the cancer. Also disclosed is a combination therapeutic comprising the first and second agents.
Claims13
(canceled)
A method for treating prostate cancer in a subject, the method comprising co-administering to a subject in need thereof, a therapeutically effective amount of J591-Ac225 and a therapeutically effective amount of a PSMA-Lu177 peptide.
Dependencies are inferred from the claim text.